AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 158 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,445,000 | +150.9% | 69,043 | +149.7% | 0.01% | +175.0% |
| Q2 2019 | $576,000 | -29.0% | 27,651 | -6.9% | 0.00% | 0.0% |
| Q3 2018 | $811,000 | -70.7% | 29,706 | -71.1% | 0.00% | -73.3% |
| Q2 2018 | $2,764,000 | +63.3% | 102,799 | +93.2% | 0.02% | +66.7% |
| Q1 2018 | $1,693,000 | – | 53,199 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|